Boston Scientific (NYSE:BSX – Get Free Report) updated its second quarter 2024 earnings guidance on Wednesday. The company provided EPS guidance of 0.570-0.590 for the period, compared to the consensus EPS estimate of 0.560. The company issued revenue guidance of $4.0 billion-$4.0 billion, compared to the consensus revenue estimate of $3.9 billion. Boston Scientific also […]
Boston Scientific (NYSE:BSX – Free Report) had its price target lifted by JPMorgan Chase & Co. from $72.00 to $82.00 in a research note published on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical equipment provider’s stock. A number of other research firms have also recently commented on […]
Boston Scientific (NYSE:BSX – Get Free Report) had its target price lifted by equities research analysts at Barclays from $70.00 to $78.00 in a report released on Friday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. Barclays‘s price objective would suggest a potential upside of 6.38% from the […]
Boston Scientific (NYSE:BSX – Get Free Report) had its price target increased by analysts at Robert W. Baird from $79.00 to $84.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical equipment provider’s stock. Robert W. Baird’s target price would indicate a potential upside of […]
Boston Scientific (NYSE:BSX – Get Free Report) had its target price upped by equities researchers at Deutsche Bank Aktiengesellschaft from $63.00 to $73.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “hold” rating on the medical equipment provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential downside of […]